Cargando…

Long Non-Coding RNA (LncRNA) CASC15 Is Upregulated in Diabetes-Induced Chronic Renal Failure and Regulates Podocyte Apoptosis

BACKGROUND: CASC15 has been recently characterized as an oncogenic lncRNA. This study aimed to investigate the role of CASC15 in diabetic patients complicated with chronic renal failure (DCRF). MATERIAL/METHODS: Levels of CASC15 in plasma derived from 3 groups of participants were measured by qPCR a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Xiaohua, Zhu, Shuying, Chen, Yanxia, Chen, Dan, Tu, Weiping, Zou, Hongchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034410/ https://www.ncbi.nlm.nih.gov/pubmed/32053576 http://dx.doi.org/10.12659/MSM.919415

Ejemplares similares

LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019)

LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis
por: Zhang, Hongliang, et al.
Publicado: (2020)

Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis
por: He, Tianyu, et al.
Publicado: (2017)

LncRNA CASC15 upregulates cyclin D1 by downregulating miR-365 in laryngeal squamous cell carcinoma to promote cell proliferation
por: Zhu, Minhui, et al.
Publicado: (2022)

The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
por: Fernando, Thilini R., et al.
Publicado: (2017)

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11
por: Su, Xiaohui, et al.
Publicado: (2019)

Significance of LncRNA CASC8 genetic polymorphisms on the tuberculosis susceptibility in Chinese population
por: Liu, Guoye, et al.
Publicado: (2020)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression via Upregulation of UBE2T in a m(6)A-Dependent Manner
por: Chen, Fei, et al.
Publicado: (2021)

lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17
por: Liu, Cheng, et al.
Publicado: (2020)

Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway
por: Zhang, Yang, et al.
Publicado: (2019)

lncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-β2
por: Zhang, Zeng, et al.
Publicado: (2021)

Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis
por: Cui, Zhigang, et al.
Publicado: (2018)

lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA‐150
por: Luo, Huarong, et al.
Publicado: (2019)

LncRNA CASC11 was downregulated in coronary artery disease and inhibits transforming growth factor-β1
por: Chen, Junhua, et al.
Publicado: (2020)

MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2
por: Sun, Yun, et al.
Publicado: (2020)

LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein
por: Liang, Yan, et al.
Publicado: (2018)

LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p
por: Cheng, Nan, et al.
Publicado: (2019)

LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
por: Hsu, Wenchan, et al.
Publicado: (2019)

STAT3-Induced Upregulation of lncRNA CASC9 Promotes the Progression of Bladder Cancer by Interacting with EZH2 and Affecting the Expression of PTEN
por: Yuan, Bo, et al.
Publicado: (2020)

Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential
por: Wang, Bei, et al.
Publicado: (2020)

LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
por: Luo, Kaili, et al.
Publicado: (2019)

Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy
por: Jiao, Yingwei, et al.
Publicado: (2021)

Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
por: Sassenberg, Madeleine, et al.
Publicado: (2019)

LncRNA CASC2 is up-regulated in osteoarthritis and participates in the regulation of IL-17 expression and chondrocyte proliferation and apoptosis
por: Huang, Tao, et al.
Publicado: (2019)

LncRNA CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition
por: Su, Yanyan, et al.
Publicado: (2019)

LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy
por: Fang, Xiangdong, et al.
Publicado: (2023)

lncRNA-CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
por: Wang, Hongqi, et al.
Publicado: (2021)

lncRNA-CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
por: Wang, Hongqi, et al.
Publicado: (2022)

The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2022)

The LncRNA CASC11 Promotes Colorectal Cancer Cell Proliferation and Migration by Adsorbing miR-646 and miR-381-3p to Upregulate Their Target RAB11FIP2
por: Zhang, Wei, et al.
Publicado: (2021)

LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease via targeting miR-18a-5p/IGF1 axis
por: Liu, Panpan, et al.
Publicado: (2021)

lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway
por: Liu, Hongxia, et al.
Publicado: (2021)

LncRNA CASC15 Promotes Cerebral Ischemia/Reperfusion Injury via miR-338-3p/ETS1 Axis in Acute Ischemic Stroke
por: Chen, Chen, et al.
Publicado: (2021)

Retracted: Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
por: Li, Hui, et al.
Publicado: (2023)

Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1
por: Zhang, Yankun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m86pnspr41q7371elivgslbgso